My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 846

    1.

    Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.

    Schlicht M, Matysiak B, Brodzeller T, Wen X, Liu H, Zhou G, Dhir R, Hessner MJ, Tonellato P, Suckow M, Pollard M, Datta MW.

    BMC Genomics. 2004 Aug 20;5(1):58.PMID: 15318950 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

    Chakrabarti R, Robles LD, Gibson J, Muroski M.

    Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.PMID: 12550771 [PubMed - indexed for MEDLINE]Related articles

    3.

    Alteration of glyoxalase genes expression in response to testosterone in LNCaP and PC3 human prostate cancer cells.

    Antognelli C, Del Buono C, Baldracchini F, Talesa V, Cottini E, Brancadoro C, Zucchi A, Mearini E.

    Cancer Biol Ther. 2007 Dec;6(12):1880-8. Epub 2007 Sep 1.PMID: 18344682 [PubMed - indexed for MEDLINE]Related articles

    4.

    Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.

    Fujinami K, Uemura H, Ishiguro H, Kubota Y.

    Int J Mol Med. 2002 Aug;10(2):173-6.PMID: 12119554 [PubMed - indexed for MEDLINE]Related articles

    5.

    Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.

    Margiotti K, Wafa LA, Cheng H, Novelli G, Nelson CC, Rennie PS.

    Mol Cancer. 2007 Jun 6;6:38.PMID: 17553164 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

    Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J.

    J Natl Cancer Inst. 2009 Mar 4;101(5):306-20. Epub 2009 Feb 24.PMID: 19244175 [PubMed - indexed for MEDLINE]Related articles

    7.

    Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

    Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.

    Prostate. 2008 Oct 1;68(14):1517-30.PMID: 18668517 [PubMed - indexed for MEDLINE]Related articles

    8.

    Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

    Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

    Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.PMID: 16963837 [PubMed - indexed for MEDLINE]Related articles

    9.

    Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.

    Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE.

    Cancer Res. 2002 Sep 15;62(18):5325-35.PMID: 12235003 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.

    Tørring N, Jørgensen PE, Sørensen BS, Nexø E.

    Anticancer Res. 2000 Jan-Feb;20(1A):91-5.PMID: 10769639 [PubMed - indexed for MEDLINE]Related articles

    11.

    The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.

    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.

    Cancer Res. 1999 May 1;59(9):2203-9.PMID: 10232609 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.

    Chi SG, deVere White RW, Muenzer JT, Gumerlock PH.

    Clin Cancer Res. 1997 Oct;3(10):1889-97.PMID: 9815578 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.

    Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, Spano P.

    Clin Cancer Res. 1999 May;5(5):1211-8.PMID: 10353759 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.

    Prostate. 2006 Jul 1;66(10):1070-5.PMID: 16637076 [PubMed - indexed for MEDLINE]Related articles

    15.

    Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

    Chun JY, Hu Y, Pinder E, Wu J, Li F, Gao AC.

    Mol Cancer Ther. 2007 Sep;6(9):2572-80.PMID: 17876054 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Identification of novel androgen receptor target genes in prostate cancer.

    Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL, Buchanan G, Coetzee GA, Frenkel B.

    Mol Cancer. 2007 Jun 6;6:39.PMID: 17553165 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.

    Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P.

    Mol Cancer. 2008 Jan 21;7:7.PMID: 18208603 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.

    Peternac D, Klima I, Cecchini MG, Schwaninger R, Studer UE, Thalmann GN.

    Prostate. 2008 Sep 1;68(12):1307-18.PMID: 18512728 [PubMed - indexed for MEDLINE]Related articles

    19.

    Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells.

    Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR.

    Prostate. 1994 Apr;24(4):204-11.PMID: 8146069 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differential gene expression in human prostate cancer cells adapted to growth in bone in Beige mice.

    Soos G, Haas GP, Wang CY, Jones RF.

    Urol Oncol. 2003 Jan-Feb;21(1):15-9.PMID: 12684122 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity